Jan Biegus

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

Adriaan A. Voors, Christiane E. Angermann, John R. Teerlink et al. · Nature Medicine · 2022 · 895 citations · Full text

Medicine, Cardiology, Pharmacology +15

Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure

Ewa A. Jankowska, Monika Kasztura, Mateusz Sokolski et al. · European Heart Journal · 2014 · 249 citations · Full text

Medicine, Cardiology, Hematology +14

Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial

Jan Biegus, Adriaan A. Voors, Sean P. Collins et al. · European Heart Journal · 2022 · 214 citations · Full text

Medicine, Cardiology, Pharmacology +15

Increased Blood Lactate is Prevalent and Identifies Poor Prognosis in Patients with Acute Heart Failure without Overt Peripheral Hypoperfusion

Robert Zymliński, Jan Biegus, Mateusz Sokolski et al. · European Journal of Heart Failure · 2018 · 167 citations · Full text

Medicine, Cardiology, Clinical Cardiology +13

Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial

Mikhail Kosiborod, Christiane E. Angermann, Sean P. Collins et al. · Circulation · 2022 · 143 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17